Dr. Suyog Mokashi Provides Perspective for TCTMD Article about Study on Early Aortic Valve Replacement Strategy and Asymptomatic Patients with Evidence of Myocardial Fibrosis

Suyog A. Mokashi, MD, Director of the Aortic Surgery Program at Temple University Hospital and Assistant Professor of Surgery at the Lewis Katz School of Medicine at Temple University, provided perspective for a TCTMD.com article about the EVOLVED study, which showed an early aortic valve replacement strategy with either transcatheter aortic valve implantation (TAVI) or surgery fails to lower the risk of all-cause mortality or unplanned aortic stenosis-related hospitalizations in asymptomatic patients with evidence of myocardial fibrosis.